Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-16,148
Closed -$2.07M 97
2021
Q4
$2.07M Buy
16,148
+1,029
+7% +$159K 0.81% 63
2021
Q3
$2.17M Sell
15,119
-10,781
-42% -$1.48M 0.91% 50
2021
Q2
$3.02M Sell
25,900
-2,125
-8% -$209K 1.14% 37
2021
Q1
$2.25M Sell
28,025
-383,375
-93% -$29.2M 0.88% 45
2020
Q4
$25.8M Sell
411,400
-12,936
-3% -$738K 1.9% 16
2020
Q3
$18.1M Buy
424,336
+129,816
+44% +$5.02M 1.57% 32
2020
Q2
$10.8M Buy
294,520
+257,750
+701% +$6.82M 1.01% 49
2020
Q1
$625K Sell
36,770
-210,966
-85% -$6.72M 0.06% 99
2019
Q4
$10.4M Buy
247,736
+4,711
+2% +$165K 0.72% 55
2019
Q3
$6.75M Buy
243,025
+790
+0.3% +$19.1K 0.52% 62
2019
Q2
$4.78M Buy
242,235
+3,216
+1% +$74.5K 0.35% 80
2019
Q1
$6.16M Sell
239,019
-7,088
-3% -$194K 0.45% 71
2018
Q4
$6.39M Buy
+246,107
New +$5.76M 0.55% 62
2015
Q4
Sell
-625,000
Closed -$8.08M 158
2015
Q3
$8.08M Buy
+625,000
New +$9.06M 0.75% 58

Other funds holding CROX

Friess Associates's CROX Position: Q1 2022 in Review

Friess Associates sold out of Crocs (CROX) in Q1 2022, closing a stake of 16,148 shares — an estimated $2.07M sold.

Friess Associates first reported a position in CROX in Q3 2015 and held it in 14 quarters. The position peaked at $25.8M in Q4 2020. 378 funds tracked by Wall St. Rank hold CROX as of Q1 2022.

  • Friess Associates reported no remaining Crocs position as of Q1 2022 after selling out during the quarter.
  • Friess Associates sold 16,148 Crocs shares in Q1 2022, an estimated $2.07M.
  • Friess Associates first reported a position in Crocs in Q3 2015 and held it in 14 quarters.
  • Friess Associates's Crocs position peaked at $25.8M in Q4 2020.
  • 378 funds tracked by Wall St. Rank held Crocs as of Q1 2022.

Based on Friess Associates's 13F filing for Q1 2022, filed 12 May 2022.